Overview Fundamentals API Earnings EOD API Sample Code Pricing

Jasper Therapeutics Inc (JSPR NASDAQ) stock market data APIs

$20.06 0.96(5%) as of July 12, 2024
Price chart is built with Anychart

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

Jasper Therapeutics Inc Financial Data Overview

288 M
15 086 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'JSPR',
Type: 'Common Stock',
Name: 'Jasper Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00QPZNP97',
CIK: '1788028',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-09-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Jasper Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -68 864 000
  • Earnings Per Share -61.21
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Jasper Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -1.23

Get Jasper Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?